Overview


The PSA Test Market is a rapidly expanding global segment for blood tests that measure prostate-specific antigen to help detect and monitor prostate conditions, driven by rising cancer awareness, aging populations, and tech-led diagnostic innovations.

According to FutureWise analysis, the PSA test market in 2026 is US$4.58 billion and is expected to reach US$8.96 billion by 2036, at a CAGR of 6.94%. The growth in this market is primarily driven by a rising awareness of prostate cancer screening and advancements in diagnostic technologies. The increasing prevalence of prostate-related disorders among aging populations is also boosting demand. Furthermore, the expansion of healthcare infrastructure and the adoption of early-detection practices in emerging economies are expected to significantly drive market growth.

Growth Drivers:

  • Greater public awareness and education on prostate health.
  • Technological advancements in sensitive and accurate tests.
  • Government screening programs supporting early diagnosis.
  • At-home and convenient testing options are boosting accessibility.
  • Expansion of healthcare infrastructure in emerging markets.

Key Trends:

  • Integration of AI and digital tools for better test interpretation.
  • Growth of at-home and direct-to-consumer testing kits.
  • Shift toward personalized diagnostics with multiple biomarkers.
  • Telemedicine and digital platforms streamlining testing and follow-up.
  • Increased focus on preventive screening programs.

Market Segmentation and Key Players:

The PSA Test Market is segmented by Type (CLIA, ELISA, and other formats), Application (screening, post-treatment monitoring, etc.), and Region (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) to highlight regional demand and growth differences. Comprehensive segmentation details are provided in the Segmentation section below.

Major companies operating in the PSA Test market include Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers, known for their advanced diagnostic platforms and global reach.

Research Methodology:

The FutureWise Research PSA Test Market report uses a mix of primary research (expert interviews) and secondary research (industry reports, databases, and company data), applying data triangulation and forecasting to estimate market size, trends, and segmentation for accurate growth insights.

  • Abbott
  • Siemens Healthcare
  • DiaSorin
  • Roche
  • Beckman Coulter
  • PerkinElmer
  • Tosoh
  • Ortho Clinical
  • Fujirebio
  • Mediwatch
  • BodiTech

(Note: The list of major players will be updated with the latest market scenario and trends)

Recent developments by key players in the PSA Test Market: 

Siemens Healthineers

  • Strategic Acquisitions: In April 2025, Siemens Healthineers acquired the U.S.-based R&D scientific software company Dotmatics for $5.1 billion. This acquisition aims to enhance its Life Sciences portfolio and integrate AI-powered product lifecycle management software within its Xcelerator platform.

DiaSorin

  • Financial Performance: In the first half of 2025, DiaSorin reported a 3% growth in its Ex-COVID Molecular Diagnostics segment, which includes PSA testing. The company credits this growth to its "Legacy DiaSorin" tests and the positive impact of the multiplexing business.

Roche

  • The Elecsys PSA II assay recently received CE-IVD marking in Europe after undergoing a large multicenter clinical performance study with over 2,800 patients across Germany, France, and Italy, in accordance with EU IVDR requirements. This investment was driven by evolving regional regulations.
  • Roche is integrating AI-driven predictive analytics and multiparametric screening methods to enhance diagnostic accuracy and reduce false positives in PSA-based workflows.

Abbott

  • Abbott continues to lead in assay sensitivity via its ARCHITECT and Alinity platforms, offering detection limits as low as 0.003?ng/mL, and capturing an estimated 16–26% global PSA test market share.
  • The company is pursuing the integration of AI enhancement and combinatorial biomarker approaches to refine risk stratification and screening outcomes

Siemens Healthcare

  • Through its ADVIA Centaur and Atellica systems, Siemens commands approximately 15–18% of the PSA test market, serving thousands of labs globally with high-throughput platforms and consistent performance metrics
  • Siemens is advancing multi-parametric PSA testing strategies, incorporating additional biomarkers and contextual risk data, aligning with broader trends in precision diagnostics

By Type

  • CLIA
  • ELISA
  • Others

By Applications

  • Screening
  • Post-treatment Monitoring
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Here’s a regional view of where the most progress is happening 
North America

  • Market Leadership: In 2024, North America had the largest market share in prostate cancer diagnostics, attributed to its advanced healthcare infrastructure, high levels of awareness, and widespread use of PSA testing.
  • Projected Growth: The U.S. prostate cancer diagnostics market is expected to reach approximately USD 4.65 billion by 2030, growing at a CAGR of 5.3% from 2024 to 2030


  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the PSA Test Market By Type, By Applications and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   PSA Test Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of PSA Test Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   PSA Test Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   PSA Test Market, By Type Historical Analysis and Forecast 2026-2036 (USD Million)

    •   1. CLIA
        2. ELISA
        3. Others

  • 8.   PSA Test Market, By Applications Historical Analysis and Forecast 2026-2036 (USD Million)

    •   1. Screening
        2. Post-treatment Monitoring
        3. Others

  • 9.   North America PSA Test Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2026-2036

  • 10.   Latin America PSA Test Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2026-2036

  • 11.   Europe PSA Test Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2026-2036

  • 12.   Asia Pacific PSA Test Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2026-2036

  • 13.   Middle East and Africa Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2026-2036

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Abbott
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Siemens Healthcare
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. DiaSorin
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Roche
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Beckman Coulter
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. PerkinElmer
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Tosoh
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Ortho Clinical
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Fujirebio
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Mediwatch
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. BodiTech
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 17.   FutureWise SME Key Takeaway Points for Client

FAQ


The PSA (Prostate-Specific Antigen) test market pertains to the worldwide sector dedicated to diagnostic tests that assess PSA levels in the bloodstream for the purpose of identifying and tracking prostate cancer as well as other prostate-related conditions.
  • Introduction of AI-based PSA tests to improve detection accuracy.
  • Expansion of high-throughput automated systems.
  • Launch of multi-cancer screening tests leveraging PSA markers
  • Rising incidence of prostate cancer among aging populations.
  • Increased awareness and adoption of early detection screening.
  • Technological advancements in diagnostics and automation.

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 113 519 7222
  • US : +1 347 709 4931

Related Market

Prostate Specific Antigen (PSA) Blood-Based Biomarker Market

Read More

Prostate-specific antigen (PSA) Market

Read More

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11